Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· FoundMyFitness Clips

Why "second generation" epigenetic clocks are better at detecting biological age | Dr. Morgan Levine

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original language

When we talk about epigenetic clocks, one of the key innovations of the last few years has been the development of techniques to reduce statistical noise to make them more accurate at detecting biological age. Put another way, there is a big difference between first-generation and second-generation epigenetic clocks. The second-generation clocks go a step beyond tracking chronological age by statistically regressing more conventional health-related biomarkers. This differentiating strategy used in new epigenetic clocks, namely PhenoAge and GrimAge, may be really important in future trial design for many studies. Listen as recent podcast guest from episode 72 of the FoundMyFitness podcast, Dr. Morgan Levine, describes the importance of this step in making her epigenetic clock PhenoAge and that of her postdoctoral mentor GrimAge more accurate in their ability to detect biological age and epigenetic age acceleration. Full episode can be found here: https://youtu.be/_dOofH4PC9w

FoundMyFitness Clips · 5 min · Source published: 2022-04-13

Added to Harbor: 10/22/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…